We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Retain Equifax (EFX) Stock for Now
Read MoreHide Full Article
Equifax Inc. (EFX - Free Report) is currently benefiting from its technology transformation and strong customer base.
EFX’s revenues for 2022 and 2023 are expected to improve 3.6% from the respective year-ago reported figures.
Factors That Augur Well
Equifax’s ongoing cloud data and technology transformation aims to drive innovation and product development, and strengthen customer and partner integration. As part of the shift, EFX is migrating to a public cloud environment involved in virtual private cloud deployment techniques. EFX is focused on streamlining customers’ access to its analytical platforms.
Moreover, EFX concentrates on expanding and strengthening its customer base with efforts to deliver multi-data solutions by expanding differentiated data assets and analytics through organic growth, mergers and acquisitions, and partnerships. Equifax uses proprietary advanced analytical platforms, machine learning, artificial intelligence and advanced visualization tools.
A Risk
Equifax's current ratio at the end of the September quarter was pegged at 0.64, lower than 1.53 reported at the end of the prior-year quarter. A decreasing current ratio is not desirable as it highlights a company’s difficulty in fulfilling its short-term debt obligations.
Image: Bigstock
Here's Why You Should Retain Equifax (EFX) Stock for Now
Equifax Inc. (EFX - Free Report) is currently benefiting from its technology transformation and strong customer base.
EFX’s revenues for 2022 and 2023 are expected to improve 3.6% from the respective year-ago reported figures.
Factors That Augur Well
Equifax’s ongoing cloud data and technology transformation aims to drive innovation and product development, and strengthen customer and partner integration. As part of the shift, EFX is migrating to a public cloud environment involved in virtual private cloud deployment techniques. EFX is focused on streamlining customers’ access to its analytical platforms.
Moreover, EFX concentrates on expanding and strengthening its customer base with efforts to deliver multi-data solutions by expanding differentiated data assets and analytics through organic growth, mergers and acquisitions, and partnerships. Equifax uses proprietary advanced analytical platforms, machine learning, artificial intelligence and advanced visualization tools.
A Risk
Equifax's current ratio at the end of the September quarter was pegged at 0.64, lower than 1.53 reported at the end of the prior-year quarter. A decreasing current ratio is not desirable as it highlights a company’s difficulty in fulfilling its short-term debt obligations.
Zacks Rank and Stocks to Consider
Equifax currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the broader Zacks Business Services sector are Booz Allen Hamilton Holding Corporation (BAH - Free Report) , Paychex, Inc. (PAYX - Free Report) and Cross Country Healthcare, Inc. (CCRN - Free Report) .
Booz Allen carries a Zacks Rank #2 (Buy) at present. BAH has a long-term earnings growth expectation of 8.9%.
Booz Allen delivered a trailing four-quarter earnings surprise of 8.8%, on average.
Paychex carries a Zacks Rank of 2 at present. PAYX has a long-term earnings growth expectation of 7.5%.
Paychex delivered a trailing four-quarter earnings surprise of 8.6%, on average.
Cross Country Healthcare is currently Zacks #2Ranked. CCRN has a long-term earnings growth expectation of 6%.
CCRN delivered a trailing four-quarter earnings surprise of 10.1%, on average.